BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38756153)

  • 1. Landscape of cancer clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-India.
    Gao P; Chen J; Hong Z; Choi M; Morgan A; Petushkov A; Lall R; Liu C; Muddu VK; Arroju V; Sunkavalli C; Kim G; Reddy BY
    Lancet Reg Health Southeast Asia; 2024 May; 24():100323. PubMed ID: 38756153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in dentistry in India: Analysis from trial registry.
    Gowri S; Kannan S
    Perspect Clin Res; 2017; 8(2):95-99. PubMed ID: 28447021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in India: Where do we stand globally?
    Selvarajan S; George M; Kumar SS; Dkhar SA
    Perspect Clin Res; 2013 Jul; 4(3):160-4. PubMed ID: 24010056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public disclosure of clinical trial results at Clinical Trial Registry of India- Need for transparency in research!
    Munshi R; Pilliwar C; Maurya MR
    Perspect Clin Res; 2023; 14(2):81-85. PubMed ID: 37325584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020.
    Shree Devi MS; Sathiyarajeswaran P; Kanakavalli K; Vinod NP; Baskar V
    J Ayurveda Integr Med; 2021; 12(2):346-350. PubMed ID: 34024689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Audit of Clinical Studies Involving Elderly Population Registered in Clinical Trials Registry of India.
    Sharma AA; Karekar SR; Shetty YC
    J Midlife Health; 2021; 12(1):61-65. PubMed ID: 34188428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer awareness, diagnosis and treatment needs in Mizoram, India: evidence from 18 years trends (2003-2020).
    Zomawia E; Zami Z; Vanlallawma A; Kumar NS; Zothanzama J; Tlau L; Chhakchhuak L; Pachuau L; Pautu JL; Hmangaihzuali EVL
    Lancet Reg Health Southeast Asia; 2023 Oct; 17():100281. PubMed ID: 37780980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Publication of neurology clinical trials registered with clinical trial registry of India: A cross-sectional study.
    Mishra B; Agarwal A; Nilima N; Srivastava MVP; Vishnu VY
    Acta Neurol Scand; 2022 Nov; 146(5):475-484. PubMed ID: 35841133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of studies registered retrospectively with the Clinical Trials Registry of India: A one year analysis.
    Birajdar AR; Bose D; Nishandar TB; Shende AA; Thatte UM; Gogtay NJ
    Perspect Clin Res; 2019; 10(1):26-30. PubMed ID: 30834204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need to reinvigorateTuberculosis research in India - A review of studies registered under clinical trial registry of India.
    James J; Jamuna Rani R; Sathyanarayanan V; Sudha K
    Indian J Tuberc; 2023 Jan; 70(1):23-28. PubMed ID: 36740313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries.
    Ndwandwe D; Runeyi S; Mathebula L; Wiysonge C
    Trials; 2022 Nov; 23(1):945. PubMed ID: 36397105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study.
    Mendiratta J; Vaswani RN; Saberwal G
    PLoS One; 2023; 18(9):e0284434. PubMed ID: 37729309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
    Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
    Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
    India State-Level Disease Burden Initiative Cancer Collaborators
    Lancet Oncol; 2018 Oct; 19(10):1289-1306. PubMed ID: 30219626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trials Registry - India: A decadal perspective.
    Rao MVV; Maulik M; Juneja A; Adhikari T; Sharma S; Gupta J; Panchal Y; Yadav N
    Indian J Pharmacol; 2020; 52(4):272-282. PubMed ID: 33078728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
    Sharma H; Parekh S; Pujari P; Shewale S; Desai S; Bhatla N; Joshi S; Pimple S; Kawade A; Balasubramani L; Thomas A; Suri V; Lalwani S; Uday R; Kamath V; Mandal R; Rajeswar A; Peedicayil A; Poli UR; Banerjee D; Sankaranarayanan R; Basu P; Muwonge R; Gairola S; Dogar V; Rao H; Shaligram U
    Lancet Oncol; 2023 Dec; 24(12):1321-1333. PubMed ID: 37949086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.